Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

Waystar Holding Corp.

WAYNASDAQ
Wall Street Score · overall investment34/100
$28.92USD+$0.90 (+3.21%)
Company website waystar.com
Headquarters1550 Digital Drive, Lehi, UT, 84043, US
Financial statement currencyUSD · no FX conversion applied
Healthcare · Medical - Healthcare Information Services
Price from Oct 29, 2026Financials updated Oct 26, 2026

WAY · Price history

Price at last available close

$28.92

+$3.85 (+15.36%) 1M

2026-10-28

Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.

Company & revenue

About Waystar Holding Corp.

Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.

Who they are

Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry. Their comprehensive system offers a suite of functionalities, including pre-approving finances, supporting patients with billing, overseeing claims and payments, actively preventing and recovering denied claims, enhancing revenue capture, and providing insightful analytics and reporting. The company's main clientele operates within the healthcare sector.

How they make money

Waystar operates a cloud-based software platform that simplifies healthcare payments for providers. The company generates revenue primarily through transactional volumes and claims processing; as clients serve more patients and process more transactions, Waystar's revenue grows accordingly, supplemented by clients adopting additional solutions over time.

Products & services

AI-powered cloud software platform for healthcare payments, including claims management, patient payments, and reimbursement workflow automation.

Brands & revenue mix

Waystar

Primary brand for the company's healthcare payment software platform.

Separate brand revenue is not available in this research.Source

Waystar AltitudeAI

Proprietary AI engine used to improve platform performance.

Separate brand revenue is not available in this research.Source

Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.

Product / operating segments

No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.

Geographic revenue

No reconciled geographic revenue breakdown was confirmed for the current research period.

Customer types

Customer concentration

For the year ended December 31, 2025, the top 10 clients accounted for 10.8% of total revenue.

Suppliers, materials & equipment

  • Cloud infrastructure and data center providers — The company relies on third-party cloud hosting and data center services to host its software platform and process transactions.Source

Strengths

  • Proprietary AI engine (Waystar AltitudeAI)Source
  • Highly diversified client baseSource

Risks

  • Dependence on third-party cloud infrastructureSource
  • Changes in healthcare regulations and reimbursement policiesSource

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

34

Poor

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

54

Fair

Financial Strength

56

Business Quality / Moat

78

Management

32

Growth Quality

63

Risk / Durability

19

Weak Company · Expensive Stock

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Opportunity

Opportunity Score · How does the current price compare with estimated value?

36

Avoid

Based on current valuation, company quality, recent trends, and available market signals.

View score details →

Model Outlook

12-month model · What does the model think happens next?

44/100

Building Historical Record

Model Score 44/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.

Probability unavailable — the model has not produced a calibrated probability yet.

Click for full breakdown →

WSS View

The quick read

The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.

At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.

The model outlook is currently cautious.

What we like
  • •Asset quality scores strongly
What to watch
  • •Valuation is a weaker part of the current profile
  • •Revenue fundamentals are weak

Company-specific research

Questions worth answering for WAY

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

  • •Can WAY maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • •Is WAY's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
  • •Is WAY's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • •What future growth or profitability would be needed to justify WAY's current valuation?
Business analysis: 16 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

34

0–100 · Poor

Opportunity Score

36

0–100 · Weak

Market Cap

$5.55B

P/E Ratio

40.0

EPS

$0.72

52-Week High

$40.35

52-Week Low

$17.26

Beta

0.07

Intrinsic Value

$27.72

Analyst Target

$33.00

Shares Outstanding

184.8M

Total Revenue

$1.21B

Total Debt

$1.48B

Dividend

No current dividend

View dividend history

Liquidation Value / Share

$21.57

Estimated net asset value per share

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals
Momentum
78/ 100
-10 pts / 5d

Building upward momentum

5D +0.3% · 20D +14.1% · RSI 68 · Price vs 20D avg +5.8%
Volatility
34/ 100
+3 pts / 5d

Low movement

20D realized vol 40.4% · 60D 41.2% · Acceleration 0.98x
Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Community Sentiment

0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)

No personal call yet on WAY.

Potential upside factors

  • +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
  • +Proprietary AI engine (Waystar AltitudeAI).
  • +Highly diversified client base.
  • +Positive free cash flow may provide capacity to invest in growth.

Potential downside factors

  • −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Healthcare Information Services industry.
  • −Dependence on third-party cloud infrastructure.
  • −Changes in healthcare regulations and reimbursement policies.

These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown
Wall Street Score
Weak34/ 100
Weak (0–50)Fair (51–71)Strong (72+)

Poor

34

Tap for breakdown →

Fair

61

Debt Cost5.2%
Debt Reduction YoY-18.0%
Debt / Equity0.38x

Tap for breakdown →

Poor

33

Revenue YoY9.7%
Revenue CAGR17.9%
Net Margin11.2%

Tap for breakdown →

Strong

72

Asset Growth YoY26.4%
Liquidation/Share$21.57
Net Assets/MCap0.79x

Tap for breakdown →

Poor

10

Earnings Yield2.4%
Buyback Yield0.0%
Debt Cost5.2%

Tap for breakdown →

Poor

32

ROIC3.2%
ROE3.4%
ROA2.3%

Tap for breakdown →

Strong

78

EPS Growth—
FCF/Share Growth52.7%
Rev/Share Growth3.3%

Tap for breakdown →

Poor

10

Intrinsic Value$27.72
Value Reference$16.63
MOS-3.9%

Tap for breakdown →

Fair

50

Revenue33
Moat78
Valuation10

Tap for breakdown →

Poor

0

MOS %-3.9%
Value Reference$16.63
Deep Discount Reference$11.09

Tap for breakdown →

Poor

15

Interest Coverage3.2x
ROIC3.2%
FCF Yield5.1%

Tap for breakdown →

Poor

23

Financial15
Valuation10
Debt61

Tap for breakdown →

Fair

58

Survival Years0.5 yrs
Current Ratio1.41x
FCF Margin25.8%

Tap for breakdown →

Was this stock page easy to understand?

One click helps us improve the research experience. This is not tied to an investment decision.

Score Changes

3 historical score records available

Previous Score

38

Oct 1, 2026

Change

-3.8

points

Current Score

34

Oct 26, 2026

Category Changes

Revenue-0.6
Debt0
Assets-3.5
Capital-2.0
Management0
Moat0
Valuation-15.4
Buffett-2.2

WAY decreased 3.8 points because Asset declined by 3.5 points, Capital declined by 2 points, Valuation declined by 15.4 points.

Negative Contributors

  • − Asset declined by 3.5 points
  • − Capital declined by 2 points
  • − Valuation declined by 15.4 points
  • − Buffett declined by 2.2 points

Projected Score

Projected Score

32

Projected Change

-1.6 points

Preliminary comparable-period financial changes suggest decline of approximately 1.6 points. This is a projected estimate, not the official WallStreetScore.

Price vs. Value

Near Fair Value

Current Price

$28.92

Model Intrinsic Value

$27.72

Difference

+$1.20

+4.3% vs IV

Margin of Safety

-4.3%

UndervaluedFair ValueOvervalued
Value Reference: $16.63
Deep Discount Reference: $11.09

Financial Charts

Revenue

20212022202320242025$0$300M$600M$900M$1.2B

Additional Metrics

Operating Cash Flow

20212022202320242025$0$80M$160M$240M$320M

Total Debt

20212022202320242025$0$600M$1.2B$1.8B$2.4B

Total Assets

20212022202320242025$0$1.5B$3.0B$4.5B$6.0B

Net Margin %

No data
Monetary values in USD. Share counts in raw units.

Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.

Line ItemTTM20252024202320222021
Revenue$1.21B$1.10B$943.5M$791.0M········
Cost of Revenue$372.5M$348.2M$315.7M$249.8M········
Gross Profit$833.2M$751.1M$627.8M$541.2M········
Research & Development$67.0M$54.6M$48.8M$35.3M········
SG&A Expenses$333.8M$306.6M$268.7M$187.4M········
Operating Expenses$557.5M$501.8M$504.1M$399.2M········
EBITDA$432.4M$389.9M$310.4M$318.6M········
Operating Income$275.8M$249.3M$123.7M$142.1M········
Interest Expense$80.7M$77.5M$146.3M$205.9M········
Income Before Tax$195.1M$171.8M-$22.5M-$63.8M········
Income Tax Expense$60.3M$59.7M-$3.4M-$12.5M········
Net Income$134.8M$112.1M-$19.1M-$51.3M········
Basic EPS$0.72$0.63$-0.13$-0.31········
Basic Shares192M178M150M167M········
Diluted Shares195M185M150M167M········
Upgrade to Premium for up to 10 annual periods, where available.
Upgrade to Premium

Earnings Summary

Estimated earnings date:Nov 2, 2026
Estimated EPS: $0.41Estimated revenue: $323.4M
Jun 30, 2026Q2FY2026

Revenue

$319.7M

Estimate unavailable.

Revenue Beat/Miss

Not available (no estimate stored)

EPS

$0.21

Estimate unavailable.

EPS Beat/Miss

Not available (no estimate stored)

Debt Change

+18.0%

Cash Change

-95.6%

Margin Change

+0.9 pp

Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.

Financial Changes Since Prior Period

What Improved

  • Margins expanded

What Weakened

  • Cash position declined
  • Debt increased

Potential Score Impact

Positive indicators included revenue growth, EPS growth, net income margin. Pressure indicators included cash levels, debt levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.

Stored Earnings Analysis

Revenue increased 18.1%. EPS increased 16.7%. Cash declined 95.6%. Total debt increased 18.0%. Net income margin improved by 0.9 percentage points.

Earnings-Call Transcript

Earnings-call transcript analysis is not currently available.

These results may influence future scores when the next evaluation is completed.

Upgrade to Premium to unlock all earnings history.View plans
Earnings data: 120 days ago · Stale

Insider Activity

Guru / Smart Money

Guru Score

Smart Money

Number of Gurus

Total Guru Value

Avg Portfolio Weight

Largest Holder

Largest Holder %

New Positions

Increased Positions

Reduced Positions

Exited Positions

Net Guru Sentiment

Short Interest

Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.

Dividend History

Dividend data is not available yet. Missing data does not mean this company pays no dividend.

Conservative Projected Values

3 Years

$———.——

Premium

5 Years

$———.——

Premium

10 Years

$———.——

Premium

Conservative Projection Rate

——%

Premium

Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.

Conservative Projected Values

Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.

Start 7-Day Free Trial

Historical Outperformance Record

Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.

Start 7-Day Free Trial

Historical Trends

3 historical records
Jul 24, 26Oct 1, 26Oct 26, 260255075100

Historical Score Chart

3 of 3 records shown

Wall Street Score

Jul 24, 26Oct 1, 26Oct 26, 260255075100

Debt Score

Jul 24, 26Oct 1, 26Oct 26, 260255075100

Revenue Score

Jul 24, 26Oct 1, 26Oct 26, 260255075100

Asset Score

Jul 24, 26Oct 1, 26Oct 26, 260255075100

Capital Score

Jul 24, 26Oct 1, 26Oct 26, 260255075100

Management Score

Jul 24, 26Oct 1, 26Oct 26, 260255075100

Moat Score

Jul 24, 26Oct 1, 26Oct 26, 260255075100

Valuation Score

Jul 24, 26Oct 1, 26Oct 26, 260255075100

Buffett Score

Jul 24, 26Oct 1, 26Oct 26, 260255075100

Intrinsic Value

Jul 24, 26Oct 1, 26Oct 26, 26$24.00$25.00$26.00$27.00$28.00

Value Reference

Jul 24, 26Oct 1, 26Oct 26, 26$14.40$15.00$15.60$16.20$16.80

Margin of Safety %

Jul 24, 26Oct 1, 26Oct 26, 26-0.0%0.0%0.0%0.1%0.1%

Related Companies

Medical - Healthcare Information Services

DOCS

Doximity, Inc.

55Fair
$34.03View

HQY

HealthEquity, Inc.

48Weak
$101.50View

OPRX

OptimizeRx Corp.

43Weak
$9.08View

OMDA

Omada Health

42Weak
$19.34View

PRVA

Privia Health Group, Inc.

41Weak
$22.93View

CCLD

CareCloud, Inc.

41Weak
$1.82View

News

Rumor Mill · WAY

Corporate developments & opportunities

Explore market →

No reviewed developments match this filter.

Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.

Related Stock Research

Continue researching this company with related Wall Street Score rankings and investing guides.

Highest Wall Street Score stocksBest growth stocksBest healthcare stocksHow Wall Street Score worksHow to analyze a stockUnderstanding financial healthIntrinsic value guide

Score Alerts

Premium unlocks alerts when a score rises, falls, or reaches your target price.

Start 7-Day Free Trial

Portfolio Score

Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.

Start 7-Day Free Trial